Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 17701 - 17725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	ACAT2	39	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ACAT2 mRNA	6q25.3	A21749
Copper	Approved Investigational	ACKR3	57007	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ACKR3 mRNA	2q37.3	A21749
Copper	Approved Investigational	ACOX2	8309	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ACOX2 mRNA	3p14.3	A21749
Copper	Approved Investigational	ACSL1	2180	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ACSL1 mRNA	4q35.1	A21749
Copper	Approved Investigational	ACSL3	2181	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ACSL3 mRNA	2q36.1	A21749
Copper	Approved Investigational	ACSS1	84532	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ACSS1 mRNA	20p11.21	A21749
Copper	Approved Investigational	ACSS2	55902	upregulated	[Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA	20q11.22	A21750
Copper	Approved Investigational	ACTA2	59	upregulated	[Disulfiram binds to Copper] which results in increased expression of ACTA2 mRNA	10q23.31	A21750
Copper	Approved Investigational	ACTR3	10096	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ACTR3 mRNA	2q14.1	A21749
Copper	Approved Investigational	ACYP2	98	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ACYP2 mRNA	2p16.2	A21749
Copper	Approved Investigational	ADAM17	6868	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ADAM17 mRNA	2p25.1	A21749
Copper	Approved Investigational	ADAM9	8754	upregulated	[Disulfiram binds to Copper] which results in increased expression of ADAM9 mRNA	8p11.22	A21750
Copper	Approved Investigational	ADAMTS1	9510	downregulated	[Disulfiram binds to Copper] which results in decreased expression of ADAMTS1 mRNA	21q21.3	A21750
Copper	Approved Investigational	ADAMTS3	9508	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ADAMTS3 mRNA	4q13.3	A21749
Copper	Approved Investigational	ADARB1	104	upregulated	[Disulfiram binds to Copper] which results in increased expression of ADARB1 mRNA	21q22.3	A21750
Copper	Approved Investigational	ADCY3	109	upregulated	[Disulfiram binds to Copper] which results in increased expression of ADCY3 mRNA	2p23.3	A21750
Copper	Approved Investigational	ADGRD1	283383	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ADGRD1 mRNA	12q24.33	A21749
Copper	Approved Investigational	ADGRE5	976	upregulated	[Disulfiram binds to Copper] which results in increased expression of ADGRE5 mRNA	19p13.12	A21750
Copper	Approved Investigational	ADGRF1	266977	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ADGRF1 mRNA	6p12.3	A21749
Copper	Approved Investigational	ADGRF4	221393	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ADGRF4 mRNA	6p12.3	A21749
Copper	Approved Investigational	ADGRG1	9289	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ADGRG1 mRNA	16q21	A21749
Copper	Approved Investigational	ADGRL1	22859	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ADGRL1 mRNA	19p13.12	A21749
Copper	Approved Investigational	ADM	133	downregulated	[Disulfiram binds to Copper] which results in decreased expression of ADM mRNA	11p15.4	A21750
Copper	Approved Investigational	ADM	133	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ADM mRNA	11p15.4	A21749
Copper	Approved Investigational	ADPRM	56985	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ADPRM mRNA	17p13.1	A21749

Displaying entries 17701 - 17725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability